MET and breast carcinoma: For example, breast cancer cell lines resistant to NVP-BEZ235 have increased JAK2/STAT5 activation resulting from IL-8 secretion.50 Along these lines, combined treatment with GDC-0980 together with a c-Met inhibitor efficiently inhibited mesothelioma tumor growth in vivo.